Compare MTX & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTX | CLOV |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2004 | 2020 |
| Metric | MTX | CLOV |
|---|---|---|
| Price | $77.91 | $4.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $82.00 | $2.90 |
| AVG Volume (30 Days) | 214.5K | ★ 7.7M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | ★ 1.17 | 0.05 |
| Revenue | ★ $2,072,600,000.00 | $1,924,308,000.00 |
| Revenue This Year | $5.66 | $52.59 |
| Revenue Next Year | $4.47 | $15.37 |
| P/E Ratio | ★ $66.48 | $84.00 |
| Revenue Growth | N/A | ★ 40.34 |
| 52 Week Low | $53.15 | $1.58 |
| 52 Week High | $84.34 | $4.23 |
| Indicator | MTX | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 55.44 | 82.55 |
| Support Level | $65.38 | $2.44 |
| Resistance Level | $84.34 | N/A |
| Average True Range (ATR) | 2.25 | 0.23 |
| MACD | -0.26 | 0.04 |
| Stochastic Oscillator | 40.19 | 91.52 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.